About: http://data.cimple.eu/news-article/5960f2f0ccdc60625c4d225908ab0b7f93eb719faf41ae075e196f95

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/5960f2f0ccdc60625c4d225908ab0b7f93eb719faf41ae075e196f95 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The European Union has agreed to fast-track approvals of vaccines updated to target coronavirus variants, the bloc's health commissioner said Sunday, following criticism of the EU's sluggish vaccine drive. "We looked at the process together with the European Medicines Agency (EMA)," Stella Kyriakides told German daily Augsburger Allgemeine in an interview. "And we have now decided that a vaccine, which has been improved by a manufacturer based on its previous vaccine to combat new mutations, no longer has to go through the entire approvals process. "So it will be faster to have suitable vaccines available without cutting corners on safety," she said. The EU's vaccine rollout has been snagged by delays and controversies, leaving it lagging behind countries like the United States, Britain and Israel where a larger share of the population has been injected so far. European Commission chief Ursula von der Leyen last week admitted that mistakes had been made in procuring vaccines on behalf of all 27 member states. She told the European Parliament that the bloc had been late to authorise jabs, and had underestimated the difficulties of vaccine mass production. She also warned that scientists do not yet know if the vaccines approved so far -- those by BioNTech/Pfizer, Moderna and AstraZeneca/Oxford -- will remain effective against new mutations. "But we do know these variants will continue to emerge. And we do know that we need to anticipate and prepare immediately," she said. mfp/spm
schema:headline	EU to fast-track jabs against virus variants
schema:mentions	European Parliament European Commission European Medicines Agency Ebola virus disease University of Oxford Ursula von der Leyen AstraZeneca Israel European Union Pfizer Vaccine United States Severe acute respiratory syndrome coronavirus 2 Augsburger Allgemeine Stella Price
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-14 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software